India Early Toxicity Testing Market

1      INTRODUCTION

           1.1      REPORT DESCRIPTION

           1.2      RESEARCH METHODOLOGY

                         1.2.1      SECONDARY RESEARCH

                         1.2.2      DATA ANALYSIS FRAMEWORK

                         1.2.3      MARKET SIZE ESTIMATION

                         1.2.4      FORECASTING

                         1.2.5      PRIMARY RESEARCH AND DATA VALIDATION

2      INDIA EARLY TOXICITY TESTING MARKET – EXECUTIVE SUMMARY

           2.1.      MARKET SNAPSHOT, 2023 - 2030, Million USD

3      PORTER’S FIVE FORCE MODEL ANALYSIS

           3.1      BARGAINING POWER OF SUPPLIERS

           3.2      BARGAINING POWER OF BUYERS

           3.3      DEGREE OF COMPETITION

           3.4      THREAT OF SUBSTITUTE

           3.5      THREAT OF NEW ENTRANTS

4      MARKET SHARE ANALYSIS

           4.1      MARKET SHARE ANALYSIS OF TOP PROVIDERS, 2023

5      MARKET DYNAMICS

           5.1      GROWTH DRIVERS

                         5.1.1      DRIVER 1

                         5.1.2      DRIVER 2

                         5.1.3      DRIVER 3

                         5.1.4      DRIVER 4

           5.2      CHALLENGES

                         5.2.1      CHALLENGE 1

                         5.2.2      CHALLENGE 2

                         5.2.3      CHALLENGE 3

                         5.2.4      CHALLENGE 4

           5.3      OPPORTUNITIES

                         5.3.1      OPPORTUNITY 1

                         5.3.2      OPPORTUNITY 2

6       INDIA EARLY TOXICITY TESTING MARKET BY TECHNIQUE

           6.1      OVERVIEW

           6.2      IN VIVO MARKET

           6.3      IN VITRO MARKET

                         6.3.1      Cell Culture

                         6.3.2      PCR

                         6.3.3      ELISA

                         6.3.4      Western Blotting

                         6.3.5      Protein Binding Assays

           6.4      IN SILICO MARKET

7       INDIA EARLY TOXICITY TESTING MARKET BY TOXICITY ENDPOINT

           7.1      OVERVIEW

           7.2      GENOTOXICITY MARKET

           7.3      DERMAL TOXICITY MARKET

           7.4      SKIN TOXICITY MARKET

           7.5      OCULAR TOXICITY MARKET

           7.6      PHOTOTOXICITY MARKET

           7.7      OTHERS MARKET

8       INDIA EARLY TOXICITY TESTING MARKET BY END USER

           8.1      OVERVIEW

           8.2      PHARMACEUTICAL INDUSTRY MARKET

           8.3      COSMETIC INDUSTRY MARKET

           8.4      CHEMICAL INDUSTRY MARKET

           8.5      FOOD INDUSTRY MARKET

           8.6      OTHERS MARKET

9     COMPANY PROFILES

           9.1     AURIGENE PHARMACEUTICAL SERVICES LTD.

                         9.1.1     COMPANY OVERVIEW

                         9.1.2     COMPANY SNAPSHOT

                         9.1.3     OPERATING BUSINESS SEGMENTS

                         9.1.4     PRODUCT PORTFOLIO

                         9.1.5     BUSINESS PERFORMANCE

                         9.1.6     BUSINESS SEGMENTS

                         9.1.7     GEOGRAPHIC SEGMENTS

                         9.1.8     KEY STRATEGIC MOVES AND DEVELOPMENT

                         9.1.9     PRIMARY MARKET COMPETITORS

           9.2     FREYR GLOBAL REGULATORY SOLUTIONS AND SERVICES

                         9.2.1     COMPANY OVERVIEW

                         9.2.2     COMPANY SNAPSHOT

                         9.2.3     OPERATING BUSINESS SEGMENTS

                         9.2.4     PRODUCT PORTFOLIO

                         9.2.5     BUSINESS PERFORMANCE

                         9.2.6     BUSINESS SEGMENTS

                         9.2.7     GEOGRAPHIC SEGMENTS

                         9.2.8     KEY STRATEGIC MOVES AND DEVELOPMENT

                         9.2.9     PRIMARY MARKET COMPETITORS

           9.3     GVRP

                         9.3.1     COMPANY OVERVIEW

                         9.3.2     COMPANY SNAPSHOT

                         9.3.3     OPERATING BUSINESS SEGMENTS

                         9.3.4     PRODUCT PORTFOLIO

                         9.3.5     BUSINESS PERFORMANCE

                         9.3.6     BUSINESS SEGMENTS

                         9.3.7     GEOGRAPHIC SEGMENTS

                         9.3.8     KEY STRATEGIC MOVES AND DEVELOPMENT

                         9.3.9     PRIMARY MARKET COMPETITORS

           9.4     JUBILANT BIOSYS LTD.

                         9.4.1     COMPANY OVERVIEW

                         9.4.2     COMPANY SNAPSHOT

                         9.4.3     OPERATING BUSINESS SEGMENTS

                         9.4.4     PRODUCT PORTFOLIO

                         9.4.5     BUSINESS PERFORMANCE

                         9.4.6     BUSINESS SEGMENTS

                         9.4.7     GEOGRAPHIC SEGMENTS

                         9.4.8     KEY STRATEGIC MOVES AND DEVELOPMENT

                         9.4.9     PRIMARY MARKET COMPETITORS

           9.5     SAI LIFE SCIENCES LIMITED

                         9.5.1     COMPANY OVERVIEW

                         9.5.2     COMPANY SNAPSHOT

                         9.5.3     OPERATING BUSINESS SEGMENTS

                         9.5.4     PRODUCT PORTFOLIO

                         9.5.5     BUSINESS PERFORMANCE

                         9.5.6     BUSINESS SEGMENTS

                         9.5.7     GEOGRAPHIC SEGMENTS

                         9.5.8     KEY STRATEGIC MOVES AND DEVELOPMENT

                         9.5.9     PRIMARY MARKET COMPETITORS

           9.6     VIPRAGEN

                         9.6.1     COMPANY OVERVIEW

                         9.6.2     COMPANY SNAPSHOT

                         9.6.3     OPERATING BUSINESS SEGMENTS

                         9.6.4     PRODUCT PORTFOLIO

                         9.6.5     BUSINESS PERFORMANCE

                         9.6.6     BUSINESS SEGMENTS

                         9.6.7     GEOGRAPHIC SEGMENTS

                         9.6.8     KEY STRATEGIC MOVES AND DEVELOPMENT

                         9.6.9     PRIMARY MARKET COMPETITORS

           9.7     SGS S.A.

                         9.7.1     COMPANY OVERVIEW

                         9.7.2     COMPANY SNAPSHOT

                         9.7.3     OPERATING BUSINESS SEGMENTS

                         9.7.4     PRODUCT PORTFOLIO

                         9.7.5     BUSINESS PERFORMANCE

                         9.7.6     BUSINESS SEGMENTS

                         9.7.7     GEOGRAPHIC SEGMENTS

                         9.7.8     KEY STRATEGIC MOVES AND DEVELOPMENT

                         9.7.9     PRIMARY MARKET COMPETITORS

           9.8     PERKINELMER INC.

                         9.8.1     COMPANY OVERVIEW

                         9.8.2     COMPANY SNAPSHOT

                         9.8.3     OPERATING BUSINESS SEGMENTS

                         9.8.4     PRODUCT PORTFOLIO

                         9.8.5     BUSINESS PERFORMANCE

                         9.8.6     BUSINESS SEGMENTS

                         9.8.7     GEOGRAPHIC SEGMENTS

                         9.8.8     KEY STRATEGIC MOVES AND DEVELOPMENT

                         9.8.9     PRIMARY MARKET COMPETITORS

           9.9     BIO-RAD LABORATORIES, INC.

                         9.9.1     COMPANY OVERVIEW

                         9.9.2     COMPANY SNAPSHOT

                         9.9.3     OPERATING BUSINESS SEGMENTS

                         9.9.4     PRODUCT PORTFOLIO

                         9.9.5     BUSINESS PERFORMANCE

                         9.9.6     BUSINESS SEGMENTS

                         9.9.7     GEOGRAPHIC SEGMENTS

                         9.9.8     KEY STRATEGIC MOVES AND DEVELOPMENT

                         9.9.9     PRIMARY MARKET COMPETITORS

           9.10     MERCK GROUP

                         9.10.1     COMPANY OVERVIEW

                         9.10.2     COMPANY SNAPSHOT

                         9.10.3     OPERATING BUSINESS SEGMENTS

                         9.10.4     PRODUCT PORTFOLIO

                         9.10.5     BUSINESS PERFORMANCE

                         9.10.6     BUSINESS SEGMENTS

                         9.10.7     GEOGRAPHIC SEGMENTS

                         9.10.8     KEY STRATEGIC MOVES AND DEVELOPMENT

                         9.10.9     PRIMARY MARKET COMPETITORS

LIST OF TABLES

TABLE 1. INDIA EARLY TOXICITY TESTING MARKET VALUE, BY TECHNIQUE, 2023-2030, (MILLION USD)

TABLE 2. IN VIVO, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 3. IN VITRO, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 4. CELL CULTURE, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 5. PCR, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 6. ELISA, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 7. WESTERN BLOTTING, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 8. PROTEIN BINDING ASSAYS, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 9. IN SILICO, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 10. INDIA EARLY TOXICITY TESTING MARKET VALUE, BY TOXICITY ENDPOINT, 2023-2030, (MILLION USD)

TABLE 11. GENOTOXICITY, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 12. DERMAL TOXICITY, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 13. SKIN TOXICITY, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 14. OCULAR TOXICITY, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 15. PHOTOTOXICITY, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 16. OTHERS, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 17. INDIA EARLY TOXICITY TESTING MARKET VALUE, BY END USER, 2023-2030, (MILLION USD)

TABLE 18. PHARMACEUTICAL INDUSTRY, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 19. COSMETIC INDUSTRY, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 20. CHEMICAL INDUSTRY, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 21. FOOD INDUSTRY, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 22. OTHERS, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 23. AURIGENE PHARMACEUTICAL SERVICES LTD.: COMPANY SNAPSHOT

TABLE 24. AURIGENE PHARMACEUTICAL SERVICES LTD.: OPERATING BUSINESS SEGMENTS

TABLE 25. AURIGENE PHARMACEUTICAL SERVICES LTD.: PRODUCT PORTFOLIO

TABLE 26. AURIGENE PHARMACEUTICAL SERVICES LTD.: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 27. AURIGENE PHARMACEUTICAL SERVICES LTD.: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 28. AURIGENE PHARMACEUTICAL SERVICES LTD.: KEY STRATERGY

TABLE 29. FREYR GLOBAL REGULATORY SOLUTIONS AND SERVICES: COMPANY SNAPSHOT

TABLE 30. FREYR GLOBAL REGULATORY SOLUTIONS AND SERVICES: OPERATING BUSINESS SEGMENTS

TABLE 31. FREYR GLOBAL REGULATORY SOLUTIONS AND SERVICES: PRODUCT PORTFOLIO

TABLE 32. FREYR GLOBAL REGULATORY SOLUTIONS AND SERVICES: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 33. FREYR GLOBAL REGULATORY SOLUTIONS AND SERVICES: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 34. FREYR GLOBAL REGULATORY SOLUTIONS AND SERVICES: KEY STRATERGY

TABLE 35. GVRP: COMPANY SNAPSHOT

TABLE 36. GVRP: OPERATING BUSINESS SEGMENTS

TABLE 37. GVRP: PRODUCT PORTFOLIO

TABLE 38. GVRP: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 39. GVRP: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 40. GVRP: KEY STRATERGY

TABLE 41. JUBILANT BIOSYS LTD.: COMPANY SNAPSHOT

TABLE 42. JUBILANT BIOSYS LTD.: OPERATING BUSINESS SEGMENTS

TABLE 43. JUBILANT BIOSYS LTD.: PRODUCT PORTFOLIO

TABLE 44. JUBILANT BIOSYS LTD.: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 45. JUBILANT BIOSYS LTD.: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 46. JUBILANT BIOSYS LTD.: KEY STRATERGY

TABLE 47. SAI LIFE SCIENCES LIMITED: COMPANY SNAPSHOT

TABLE 48. SAI LIFE SCIENCES LIMITED: OPERATING BUSINESS SEGMENTS

TABLE 49. SAI LIFE SCIENCES LIMITED: PRODUCT PORTFOLIO

TABLE 50. SAI LIFE SCIENCES LIMITED: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 51. SAI LIFE SCIENCES LIMITED: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 52. SAI LIFE SCIENCES LIMITED: KEY STRATERGY

TABLE 53. VIPRAGEN: COMPANY SNAPSHOT

TABLE 54. VIPRAGEN: OPERATING BUSINESS SEGMENTS

TABLE 55. VIPRAGEN: PRODUCT PORTFOLIO

TABLE 56. VIPRAGEN: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 57. VIPRAGEN: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 58. VIPRAGEN: KEY STRATERGY

TABLE 59. SGS S.A.: COMPANY SNAPSHOT

TABLE 60. SGS S.A.: OPERATING BUSINESS SEGMENTS

TABLE 61. SGS S.A.: PRODUCT PORTFOLIO

TABLE 62. SGS S.A.: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 63. SGS S.A.: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 64. SGS S.A.: KEY STRATERGY

TABLE 65. PERKINELMER INC.: COMPANY SNAPSHOT

TABLE 66. PERKINELMER INC.: OPERATING BUSINESS SEGMENTS

TABLE 67. PERKINELMER INC.: PRODUCT PORTFOLIO

TABLE 68. PERKINELMER INC.: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 69. PERKINELMER INC.: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 70. PERKINELMER INC.: KEY STRATERGY

TABLE 71. BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT

TABLE 72. BIO-RAD LABORATORIES, INC.: OPERATING BUSINESS SEGMENTS

TABLE 73. BIO-RAD LABORATORIES, INC.: PRODUCT PORTFOLIO

TABLE 74. BIO-RAD LABORATORIES, INC.: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 75. BIO-RAD LABORATORIES, INC.: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 76. BIO-RAD LABORATORIES, INC.: KEY STRATERGY

TABLE 77. MERCK GROUP: COMPANY SNAPSHOT

TABLE 78. MERCK GROUP: OPERATING BUSINESS SEGMENTS

TABLE 79. MERCK GROUP: PRODUCT PORTFOLIO

TABLE 80. MERCK GROUP: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 81. MERCK GROUP: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 82. MERCK GROUP: KEY STRATERGY

LIST OF FIGURES

FIGURE 1. BARGAINING POWER OF SUPPLIERS

FIGURE 2. BARGAINING POWER OF BUYERS

FIGURE 3. DEGREE OF COMPETITION

FIGURE 4. THREAT OF SUBSTITUTE

FIGURE 5. THREAT OF NEW ENTRANTS

FIGURE 6. INDIA EARLY TOXICITY TESTING MARKET VALUE, BY TECHNIQUE, 2023-2030, (MILLION USD)

FIGURE 7. IN VIVO, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 8. IN VITRO, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 9. CELL CULTURE, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 10. PCR, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 11. ELISA, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 12. WESTERN BLOTTING, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 13. PROTEIN BINDING ASSAYS, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 14. IN SILICO, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 15. INDIA EARLY TOXICITY TESTING MARKET VALUE, BY TOXICITY ENDPOINT, 2023-2030, (MILLION USD)

FIGURE 16. GENOTOXICITY, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 17. DERMAL TOXICITY, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 18. SKIN TOXICITY, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 19. OCULAR TOXICITY, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 20. PHOTOTOXICITY, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 21. OTHERS, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 22. INDIA EARLY TOXICITY TESTING MARKET VALUE, BY END USER, 2023-2030, (MILLION USD)

FIGURE 23. PHARMACEUTICAL INDUSTRY, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 24. COSMETIC INDUSTRY, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 25. CHEMICAL INDUSTRY, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 26. FOOD INDUSTRY, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 27. OTHERS, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 28. AURIGENE PHARMACEUTICAL SERVICES LTD.: NET SALES, (2021-2023)

FIGURE 29. AURIGENE PHARMACEUTICAL SERVICES LTD.: PRIMARY MARKET COMPETITORS

FIGURE 30. FREYR GLOBAL REGULATORY SOLUTIONS AND SERVICES: NET SALES, (2021-2023)

FIGURE 31. FREYR GLOBAL REGULATORY SOLUTIONS AND SERVICES: PRIMARY MARKET COMPETITORS

FIGURE 32. GVRP: NET SALES, (2021-2023)

FIGURE 33. GVRP: PRIMARY MARKET COMPETITORS

FIGURE 34. JUBILANT BIOSYS LTD.: NET SALES, (2021-2023)

FIGURE 35. JUBILANT BIOSYS LTD.: PRIMARY MARKET COMPETITORS

FIGURE 36. SAI LIFE SCIENCES LIMITED: NET SALES, (2021-2023)

FIGURE 37. SAI LIFE SCIENCES LIMITED: PRIMARY MARKET COMPETITORS

FIGURE 38. VIPRAGEN: NET SALES, (2021-2023)

FIGURE 39. VIPRAGEN: PRIMARY MARKET COMPETITORS

FIGURE 40. SGS S.A.: NET SALES, (2021-2023)

FIGURE 41. SGS S.A.: PRIMARY MARKET COMPETITORS

FIGURE 42. PERKINELMER INC.: NET SALES, (2021-2023)

FIGURE 43. PERKINELMER INC.: PRIMARY MARKET COMPETITORS

FIGURE 44. BIO-RAD LABORATORIES, INC.: NET SALES, (2021-2023)

FIGURE 45. BIO-RAD LABORATORIES, INC.: PRIMARY MARKET COMPETITORS

FIGURE 46. MERCK GROUP: NET SALES, (2021-2023)

FIGURE 47. MERCK GROUP: PRIMARY MARKET COMPETITORS

 

At Next Move Strategy Consulting, we understand that insightful market research is the cornerstone of successful business decisions. That's why we employ a robust and multifaceted approach, combining various methodologies to deliver the most accurate and actionable data for our clients.

Research Landscape

We navigate the world of research with two primary approaches:

Qualitative Approach

Our qualitative research methodologies involve immersive techniques such as in-depth interviews, focus groups, and observational studies. By engaging directly with individuals and stakeholders, we uncover valuable insights that quantitative data alone may overlook.

Quantitative Research

In tandem with qualitative methodologies, NMSC leverages the power of Quantitative Research to provide a robust foundation of numerical insights. Through systematic data collection and analysis, we quantify patterns, preferences, and market trends, offering a comprehensive view of the business landscape.

Our quantitative research approach employs diverse tools, including surveys, experiments, and statistical modelling. These methodologies enable us to gather data from a large and representative sample, ensuring the statistical significance of our findings. By employing structured questionnaires and standardized data collection methods, we guarantee the reliability and validity of the information we present to our clients.

Quantitative research is particularly effective in measuring the prevalence of trends, assessing market size, and gauging the impact of various factors on consumer behavior. The numerical precision attained through this approach equips our clients with actionable insights, facilitating data-driven decision-making and strategy formulation.

 

Our Specialized Toolbox for Industry-Specific Market Research

We deploy a specialized arsenal of techniques tailored to meet your unique requirements. Here's a glimpse into our comprehensive toolbox:

Information Procurement

The stage entails acquiring market data or relevant information through various sources and methodologies.

Market Research Approach

We utilize both top-down and bottom-up approaches in market research analysis to achieve a comprehensive understanding of the market dynamics, leveraging the broad perspective of industry trends and macroeconomic factors alongside detailed insights from specific segments and individual companies.

Porters Five Forces Analysis

We conduct Porter's Five Forces analysis to evaluate the competitive landscape of an industry, providing us with insights into factors that affect profitability and strategic positioning.

              

SWOT Analysis

We conduct SWOT analysis to understand market trends, identify potential threats, capitalize on opportunities, and assess our strengths and weaknesses.

Forecasting

We utilize a forecasting model to predict future consumption by considering parameters like population, economics, regulations, market competition, drivers, constraints, technology, and pricing. We also employ statistical techniques such as multilinear regression, exponential smoothing, moving average, ARIMA, and Monte Carlo simulations for accurate predictions. In econometric forecasting, we analyzed short-term and long-term event impacts, attributing values based on regulatory frameworks, economic factors, and market events.